Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity as an Inhibitor of Antiapoptotic Proteins.

Yuzhi Lu, Shuangchan Wu, Yuan Yue, Si He, Jun Li, Jun Tang, Wei Wang, Hai-Bing Zhou
Author Information
  1. Yuzhi Lu: Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences , Wuhan 430071, China.
  2. Shuangchan Wu: Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences , Wuhan 430071, China.
  3. Yuan Yue: Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences , Wuhan 430071, China.
  4. Si He: Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences , Wuhan 430071, China.
  5. Jun Li: Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences , Wuhan 430071, China.
  6. Jun Tang: Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences , Wuhan 430071, China.
  7. Wei Wang: Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences , Wuhan 430071, China.
  8. Hai-Bing Zhou: Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences , Wuhan 430071, China.

Abstract

A series of gossypol Schiff bases that were derived from unnatural linear amino acid methyl esters were identified and found to be much more potent than gossypol and ABT-199 in terms of anticancer activity. This is the first example of gossypol Schiff bases with increased activity. The investigation of the Schiff base side chain of gossypol revealed that the unique anticancer effect was achieved by the introduction of hydrophobic ester groups. The optimized products showed low micromolar pan antitumor activities against NCI-60 tumor cell lines, which is promising for further drug development. Studies on the preliminary mechanism of action for their cellular activities was also carried out with antiapoptotic protein (Bcl-2 and Mcl-1) inhibition FP assays. The molecular modeling analysis demonstrated a possible binding mode for these compounds with Bcl-2, which could explain the binding affinity of the novel gossypol Schiff bases with these proteins.

Keywords

References

  1. J Med Chem. 2003 Sep 25;46(20):4259-64 [PMID: 13678404]
  2. Nat Med. 2013 Feb;19(2):202-8 [PMID: 23291630]
  3. Breast Cancer Res Treat. 2001 Nov;70(1):11-20 [PMID: 11767000]
  4. Nat Rev Drug Discov. 2008 Dec;7(12):989-1000 [PMID: 19043450]
  5. J Med Chem. 2006 Oct 19;49(21):6139-42 [PMID: 17034116]
  6. J Agric Food Chem. 2012 Sep 12;60(36):8773-5 [PMID: 22578138]
  7. Bioorg Med Chem Lett. 2013 May 1;23(9):2619-23 [PMID: 23538114]
  8. Eur J Med Chem. 2000 Sep;35(9):805-13 [PMID: 11006482]
  9. Cell Death Dis. 2010 May 06;1:e40 [PMID: 21364647]
  10. PLoS One. 2010 Jan 18;5(1):e8755 [PMID: 20090905]
  11. J Med Chem. 1991 Nov;34(11):3301-5 [PMID: 1956050]
  12. Biomed Pharmacother. 2015 Apr;71:161-71 [PMID: 25960232]
  13. Anticancer Drugs. 2000 Mar;11(3):209-16 [PMID: 10831280]
  14. J Med Chem. 2007 Jul 12;50(14):3163-6 [PMID: 17552510]
  15. Biopolymers. 2016 Jul;105(7):393-413 [PMID: 27016043]
  16. Mol Cancer Ther. 2005 Jan;4(1):13-21 [PMID: 15657349]
  17. J Med Chem. 2010 Aug 12;53(15):5502-10 [PMID: 20684596]
  18. Eur J Med Chem. 2004 Jul;39(7):619-24 [PMID: 15236842]
  19. Cancer Lett. 1999 Jan 29;135(2):171-80 [PMID: 10096426]
  20. Science. 1982 Oct 15;218(4569):288-9 [PMID: 6750791]
  21. J Med Chem. 1986 Sep;29(9):1799-801 [PMID: 3528492]
  22. Bioorg Med Chem. 2016 Feb 1;24(3):474-83 [PMID: 26337022]
  23. Antiviral Res. 2012 Jun;94(3):276-87 [PMID: 22426469]
  24. Eur J Med Chem. 2009 Oct;44(10):3961-72 [PMID: 19447525]
  25. Eur J Med Chem. 2009 Nov;44(11):4393-403 [PMID: 19577825]
  26. J Nat Prod. 2010 May 28;73(5):998-1001 [PMID: 20462271]
  27. J Med Chem. 2013 Jan 10;56(1):15-30 [PMID: 23244564]
  28. RNA. 2009 Jun;15(6):1219-30 [PMID: 19369428]
  29. J Med Chem. 2009 Jul 23;52(14):4119-25 [PMID: 19603832]
  30. J Med Chem. 2010 Nov 25;53(22):8000-11 [PMID: 21033669]
  31. J Cell Physiol. 2009 Jan;218(1):13-21 [PMID: 18767026]

Word Cloud

Created with Highcharts 10.0.0gossypolSchiffbaseslinearaminoacidestersanticanceractivityactivitiesantiapoptoticBcl-2bindingproteinsGossypolseriesderivedunnaturalmethylidentifiedfoundmuchpotentABT-199termsfirstexampleincreasedinvestigationbasesidechainrevealeduniqueeffectachievedintroductionhydrophobicestergroupsoptimizedproductsshowedlowmicromolarpanantitumorNCI-60tumorcelllinespromisingdrugdevelopmentStudiespreliminarymechanismactioncellularalsocarriedproteinMcl-1inhibitionFPassaysmolecularmodelinganalysisdemonstratedpossiblemodecompoundsexplainaffinitynovelHydrophobicLinearEstersExhibitsEnhancedAntitumorActivityInhibitorAntiapoptoticProteins

Similar Articles

Cited By